Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Durango
Clinical trial register · Mexico

Clinical Trials in Durango, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 09 Oct 2026, 03:18 UTC
1585
Studies in scope
all four open statuses
715
Recruiting now
open to new participants
254
Lead sponsors
across recruiting studies
Top sites
Mexico City 591 Monterrey 374 Guadalajara 348 Chihuahua City 175 Mérida 133
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sanofi10 Eli Lilly and Company10 AstraZeneca6 Janssen Research & Development, LLC3 GlaxoSmithKline2
Site location
Mexico City591 Monterrey374 Guadalajara348 Chihuahua City175 Mérida133
All 197 locations
Target enrolment
to

Trials with a site in Durango

48 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Recruiting
AstraZeneca
Phase 3
2,800
Benito Juárez, Culiacán, Durango, Ecatepec de Morelos, Estado de México, Mexico City, México, Tuxpan
2026-09-01
Recruiting
AstraZeneca
Phase 3
245
Culiacán, Durango, Guadalajara, Mérida, México
2026-04-13
Recruiting
Chiesi Farmaceutici S.p.A.
Phase 2
780
Durango, Mexico City, Mérida
2025-12-17
Recruiting
Eli Lilly and Company
Phase 3
7,140
Actopan, Ciudad Madero, Cuernavaca, Culiacán, Durango, Guadalajara, Hermosillo, León
2025-12-01
Recruiting
Eli Lilly and Company
Phase 2
252
Chihuahua City, Durango, Guadajalara, Guadalajara, Mexico City, San Pedro Garza García, Tijuana, Tlalnepantla
2025-11-10
Recruiting
Eli Lilly and Company
Phase 2
531
Aguascalientes, Chihuahua City, Durango, Guadalajara, Mérida, Morelia, Querétaro, Veracruz
2025-10-22
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Aguascalientes, Apizaco, Chihuahua City, Durango, Guadalajara
2025-09-22
Recruiting
Sanofi
Phase 3
942
León, Guadalajara, Chihuahua City, Durango, Mexico City
2025-09-17
Recruiting
Sanofi
Phase 3
942
Monterrey, San Juan del Río, Durango, Mexico City, Veracruz
2025-09-16
Recruiting
AstraZeneca
Phase 2
987
Chihuahua City, Durango, Guadalajara, Mexico City, Monterrey
2025-06-27
Recruiting
Eli Lilly and Company
Phase 3
290
Aguascalientes, Chihuahua City, Ciudad Madero, Durango, Guadajalara, Guadalajara, Juriquilla, Mexico City
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Aguascalientes, Chihuahua City, Ciudad Madero, Durango, Guadajalara, Guadalajara, Juriquilla, Mexico City
2025-06-26
Recruiting
Arrowhead Pharmaceuticals
Phase 3
288
Guadalajara, Mexico City, Querétaro City, Durango
2025-04-24
Active, closed
Novartis Pharmaceuticals
Phase 3
565
Monterrey, Culiacán, Durango
2025-03-20
Recruiting
AstraZeneca
Phase 3
11,300
Acapulco, Aguascalientes, Cuauhtémoc, Cuernavaca, Culiacán, Durango, Guadalajara, Mexico City
2025-03-14
Recruiting
AstraZeneca
Phase 3
5,000
Chihuahua City, Cuauhtémoc, D.F, Durango, Guadalajara, Mazatlán, Mérida, San Luis Potosí City
2025-03-03
Active, closed
Sanofi
Phase 3
231
Chihuahua City, Durango
2025-02-12
Recruiting
GlaxoSmithKline
Phase 3
750
Durango, Tlalpan
2024-11-26
By invitation
Sanofi
Phase 2
900
Monterrey, San Juan del Río, Mérida, Chihuahua City, Durango, Veracruz
2024-09-30
Active, closed
Boehringer Ingelheim
Phase 3
11,000
Aguascalientes, Cuernavaca, Culiacán, Durango, Guadalajara, Mexico City, Mérida, Monterrey
2024-08-30
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Durango, Irapuato, Jalisco, Mexico City, Distrito Federal, Mérida, Morelia, Oaxaca City, Querétaro
2024-07-18
Active, closed
Sanofi
Phase 3
1,541
Monterrey, Aguascalientes, Durango, Veracruz
2024-05-08
Active, closed
Eli Lilly and Company
Phase 3
10,000
Actopan, Aguascalientes, Ciudad Madero, Cuauhtémoc, Ciudad de México, Cuernavaca, Durango, Guadalajara, León
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aguascalientes, Chihuahua City, Cuernavaca, Culiacán, Durango, Guadalajara, Hermosillo, León
2024-03-05
By invitation
Sanofi
Phase 3
90
San Juan del Río, Durango, Veracruz
2024-01-03
Active, closed
Incyte Corporation
Phase 3
467
Deleg. Cuauhtemoc, Durango, Monterrey, Morelia, Providencia 5TA Seccion
2023-11-29
Active, closed
Janssen Research & Development, LLC
Phase 3
420
Chihuahua City, Durango, Mérida, Querétaro
2023-08-31
Recruiting
Hoffmann-La Roche
Phase 3
100
Culiacán, Mérida, Durango
2023-06-01
Active, closed
Sanofi
Phase 2
999
Chihuahua City, Durango
2023-04-03
Active, closed
Sanofi
Phase 2
187
Mérida, Chihuahua City, Durango, Tlalnepantla
2022-11-25
Active, closed
Eli Lilly and Company
Phase 3
15,374
Aguascalientes, Chihuahua City, Ciudad Madero, Cuauhtémoc, Cuernavaca, Culiacán, Durango, Guadalajara
2022-10-11
Active, closed
Sanofi
Phase 2/3
1,856
Monterrey, Durango, Veracruz
2022-08-22
Active, closed
GlaxoSmithKline
Phase 3
3,038
Durango
2022-08-10
By invitation
Biogen
Phase 3
864
Guadalajara, Mexico City, Cuernavaca, Monterrey, Mérida, Chihuahua City, Durango
2022-06-10
Active, closed
Sanofi
Phase 4
1,339
Guadalajara, Mexico City, Monterrey, San Juan del Río, Villahermosa, Chihuahua City, Durango, Oaxaca City
2021-12-16
Recruiting
H. Lundbeck A/S
Phase 3
600
Guadalajara, Ampl San Lucas Tepetlacalco, Chihuahua City, Durango
2021-12-01
Recruiting
H. Lundbeck A/S
Phase 3
285
Guadalajara, Zapopan, Morelia, Monterrey, Culiacán, México, Chihuahua City, Durango
2021-06-30
Active, closed
AstraZeneca
Phase 3
367
Chihuahua City, Culiacán, Durango, Guadalajara, Mexicali, Mérida, México
2021-06-08
Active, closed
Biogen
Phase 3
548
Guadalajara, Mexico City, Cuernavaca, Monterrey, Mérida, Chihuahua City, Durango, Veracruz
2021-05-25
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Durango, León, Monterrey, Naucalpan, Oaxaca City, Puebla City, Querétaro
2020-11-12
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Durango, León, Mexico City, Monterrey, Naucalpan, Oaxaca City, Zapopan
2020-09-23
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
160
Culiacán, Durango
2020-07-13
Active, closed
Eli Lilly and Company
Phase 3
58
Chihuahua City, Durango, Guadalajara, México, Monterrey
2020-02-12
Recruiting
Gedeon Richter Plc.
Phase 3
330
Culiacán, Durango, Guadalajara, Guanajuato City, Mérida, Monterrey, San Luis Potosí City
2019-06-06
Recruiting
Eli Lilly and Company
Phase 3
190
Chihuahua City, Durango, Guadalajara, México, Monterrey
2019-04-05
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Aguascalientes, Durango, Mexico City, Monterrey, Zapopan
2019-01-25
Active, closed
AbbVie
Phase 3
747
Durango, León, Guadalajara
2018-03-21
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Durango, Guadalajara, León, Mexico City, México, Morelia, Zapopan
2015-11-27
Rows per page Showing 1–48 of 48
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-mexico/city/durango

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 09 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 48 of those studies with a site in Durango.

How many clinical trials are recruiting in Durango?

22 of the 48 studies on this page are recruiting new participants as of the 09 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 23 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Durango), 48 studies
PhaseStudiesRecruitingShare
Phase 3381779.2%
Phase 28516.7%
Phase 2/3102.1%
Phase 4102.1%

Most active sponsors

Lead sponsors with the most studies (Durango)
Lead sponsorStudiesRecruiting
Eli Lilly and Company106
Sanofi102
AstraZeneca65
Janssen Research & Development, LLC30
Biogen20
GlaxoSmithKline21
H. Lundbeck A/S22
AbbVie10
Alnylam Pharmaceuticals11
Aragon Pharmaceuticals, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.